Skip to main content
Watch Insiders
DYN filings

Corporate insider profile

Erick Lucera Filing Activity

Latest reported as Chief Financial Officer of Dyne Therapeutics, Inc. (DYN).

Purchase filings
0
Reported companies
1
Net open-market value
-$74,699.22
Latest transaction
Jun 25, 2026

Affiliated corporations

Reported company relationships

DYNLatest reported

Dyne Therapeutics, Inc.

Chief Financial Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 25, 2026Dyne Therapeutics, Inc. (DYN)Chief Financial OfficerSale2,362$20.37$48,114
May 13, 2026Dyne Therapeutics, Inc. (DYN)Chief Financial OfficerSale1,448$18.36$26,585